Researchers develop mAb that enhances phagocytosis of tumor cells

In a paper published in Proceedings of the National Academy of Sciences, researchers at Stanford University and colleagues describe a mAb against signal regulatory protein alpha (SIRPA; CD172a; SHPS-1) that augments tumor killing when paired with a tumor-opsonizing antibody

Read the full 398 word article

User Sign In